Edge Wealth Management’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $458K | Buy |
|
|||||
|
2025
Q2 | $220K | Hold |
|
|||||
|
2025
Q1 | $196K | Buy |
|
|||||
|
2024
Q4 | $210K | Hold |
|
|||||
|
2024
Q3 | $262K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $676K | Sell |
|
|||||
|
2023
Q4 | $2.12M | Hold |
|
|||||
|
2023
Q3 | $1.54M | Hold |
|
|||||
|
2023
Q2 | $2.47M | Sell |
|
|||||
|
2023
Q1 | $1.55M | Hold |
|
|||||
|
2022
Q4 | $1.19M | Buy |
|
|||||
|
2022
Q3 | $795K | Hold |
|
|||||
|
2022
Q2 | $381K | Buy |
|
|||||
|
2022
Q1 | $990K | Hold |
|
|||||
|
2021
Q4 | $1.17M | Hold |
|
|||||
|
2021
Q3 | $1.42M | Buy |
|
|||||
|
2021
Q2 | $881K | Hold |
|
|||||
|
2021
Q1 | $1.18M | Buy |
|
|||||
|
2020
Q4 | $679K | Buy |
|
|||||
|
2020
Q3 | $302K | Buy |
|